Pfizer has added an acquisition pact to its latest string of deals. The pharma giant said today that it is buying out Redvax, a subsidiary of Switzerland’s Redbiotec, in order to get its hands on a preclinical cytomegalovirus (CMV) vaccine candidate.

…read more

Source: Pfizer continues deal spree with Redvax CMV vaccine buyout


0 No comments